| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1048894440 |
| P356 | DOI | 10.1007/S40618-015-0282-Y |
| P698 | PubMed publication ID | 25847324 |
| P50 | author | Hasan Tarik Atmaca | Q79908220 |
| P2093 | author name string | A Albayrak | |
| A Cayir | |||
| M Kara | |||
| E Akpinar | |||
| Z Bayraktutan | |||
| D Kose | |||
| Y Cayir | |||
| R A Ugan | |||
| P2860 | cites work | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
| Endothelial loss and repair in the vascular complications of diabetes: pathogenetic mechanisms and therapeutic implications | Q26851395 | ||
| TGF-β signaling in tissue fibrosis: redox controls, target genes and therapeutic opportunities | Q27022062 | ||
| The diabetic lung--a new target organ? | Q27027639 | ||
| Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent | Q28248838 | ||
| Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats | Q28367881 | ||
| Does telmisartan prevent hepatic fibrosis in rats with alloxan-induced diabetes? | Q28582483 | ||
| Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction | Q29616762 | ||
| Bosentan | Q33150898 | ||
| Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial | Q33156379 | ||
| Type-1 diabetes induces depot-specific alterations in adipocyte diameter and mass of adipose tissues in the rat. | Q33536502 | ||
| Contrasting actions of endothelin ET(A) and ET(B) receptors in cardiovascular disease. | Q33675630 | ||
| Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus | Q34362458 | ||
| Role of endothelin-1 in acute lung injury. | Q34615080 | ||
| Pirfenidone for diabetic nephropathy | Q35012444 | ||
| Endothelial dysfunction in diabetes mellitus: role in cardiovascular disease. | Q35084599 | ||
| Glutathione peroxidase activity in obese and nonobese diabetic patients and role of hyperglycemia in oxidative stress | Q35811241 | ||
| Oxidative stress in the pathogenesis of diabetic neuropathy | Q35856228 | ||
| Endothelin antagonism in pulmonary arterial hypertension | Q36240280 | ||
| Increased sorbitol pathway activity generates oxidative stress in tissue sites for diabetic complications | Q36342634 | ||
| Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes | Q36454830 | ||
| Rapamycin inhibits transforming growth factor β1-induced fibrogenesis in primary human lung fibroblasts | Q36620443 | ||
| Diabetes care, glycemic control, complications, and concomitant autoimmune diseases in children with type 1 diabetes in Turkey: a multicenter study. | Q36772146 | ||
| Lung function changes related to diabetes mellitus | Q36847360 | ||
| Oxidative stress and endothelial dysfunction in vascular disease | Q36905196 | ||
| Microvascular complications in adolescents with type 1 diabetes mellitus | Q37271508 | ||
| Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes | Q37364903 | ||
| Tumor necrosis factor-alpha as a therapeutic target for diabetic nephropathy | Q37404218 | ||
| Comparison of reducing effect on lung injury of dexamethasone and bosentan in acute lung injury: an experimental study | Q37479567 | ||
| Potential role of endothelin-1 in pulmonary fibrosis: from the bench to the clinic | Q37589390 | ||
| Endothelial dysfunction in diabetes mellitus | Q77778745 | ||
| Diabetes mellitus induces a thickening of the pulmonary basal lamina | Q78110274 | ||
| TNF, TNF receptor type 1, and allograft inflammatory factor-1 gene polymorphisms in Japanese patients with type 1 diabetes | Q78861601 | ||
| Regulation of LPS stimulated ROS production in peritoneal macrophages from alloxan-induced diabetic rats: involvement of high glucose and PPARgamma | Q80391198 | ||
| Increased expression of cyclooxygenase-2 mediates enhanced contraction to endothelin ETA receptor stimulation in endothelial nitric oxide synthase knockout mice | Q83214940 | ||
| Soluble RAGE and malondialdehyde in type 1 diabetes patients without chronic complications during the course of the disease | Q83455635 | ||
| All-transretinoic acid ameliorates bleomycin-induced lung fibrosis by downregulating the TGF-β1/Smad3 signaling pathway in rats | Q85866042 | ||
| Endothelin in pulmonary fibrosis | Q37744240 | ||
| Current and future treatment options in idiopathic pulmonary fibrosis | Q37762276 | ||
| Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy | Q37780781 | ||
| Endothelin-1 and diabetic complications: focus on the vasculature | Q37835424 | ||
| The role of endothelin-1 in the pathogenesis of pulmonary arterial hypertension | Q37854945 | ||
| Diabetic pulmonary microangiopathy - fact or fiction? | Q37870111 | ||
| Update on potential drugs for the treatment of diabetic kidney disease. | Q38009410 | ||
| MicroRNAs, transforming growth factor beta-1, and tissue fibrosis. | Q38050081 | ||
| Chronic complications of diabetes mellitus related to the respiratory system | Q38059321 | ||
| Endothelial dysfunction in (pre)diabetes: characteristics, causative mechanisms and pathogenic role in type 2 diabetes | Q38082465 | ||
| The renal endothelium in diabetic nephropathy | Q38087656 | ||
| Diabetes mellitus, a complex and heterogeneous disease, and the role of insulin resistance as a determinant of diabetic kidney disease | Q38304382 | ||
| Mesenchymal stem cells derived in vitro transdifferentiated insulin-producing cells: A new approach to treat type 1 diabetes | Q38334043 | ||
| The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial. | Q40013771 | ||
| Effect of transforming growth factor Beta 1 on wound healing in induced diabetic rats | Q41856173 | ||
| Dual endothelin receptor antagonism prevents remodeling of resistance arteries in diabetes | Q41937431 | ||
| Structural and transport property alterations of the lung capillary endothelium in diabetes. | Q42513575 | ||
| Type 2 diabetes mellitus duration: an independent predictor of serum malondialdehyde levels | Q42929662 | ||
| The effects of polymicrobial sepsis with diabetes mellitus on kidney tissues in ovariectomized rats. | Q43058597 | ||
| Effects of combined treatment with vitamins C and E on passive avoidance learning and memory in diabetic rats | Q43189771 | ||
| Type 2 diabetes in children and adolescents | Q43276515 | ||
| Proinsulin C-peptide inhibits lipolysis in diabetic rat adipose tissue through phosphodiestrase-3B enzyme. | Q43536251 | ||
| Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study | Q43764381 | ||
| Increased activity of endogenous endothelin in patients with type II diabetes mellitus | Q44160794 | ||
| Association of biomarkers of inflammation and oxidative stress with the risk of chronic kidney disease in Type 2 diabetes mellitus in North Indian population | Q44898254 | ||
| Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension | Q45022801 | ||
| Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy | Q45034117 | ||
| Bosentan therapy for portopulmonary hypertension | Q45287821 | ||
| Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice | Q46618830 | ||
| Enhanced response of pig coronary arteries to endothelin-1 after ischemia-reperfusion. Role of endothelin receptors, nitric oxide and prostanoids | Q46769016 | ||
| Diabetic neuropathy is associated with activation of the TNF-alpha system in subjects with type 1 diabetes mellitus | Q46789853 | ||
| Improvement in cardiac function of diabetic rats by bosentan is not associated with changes in the activation of PKC isoforms | Q46827561 | ||
| Efficacy of bosentan, a dual ETA and ETB endothelin receptor antagonist, in experimental diabetes induced vascular endothelial dysfunction and associated dementia in rats. | Q46893426 | ||
| Glutathione and glutathione peroxidase in type 1 diabetic patients. | Q46934190 | ||
| Role of endothelin-1 in diabetes mellitus | Q47785214 | ||
| Role of NF-kappaB-mediated interleukin-8 expression in intraocular neovascularization | Q47994624 | ||
| Protective effect of Et-1 receptor antagonist bosentan on paracetamol induced acute liver toxicity in rats. | Q51165851 | ||
| Impact of oxidative stress on the endothelial dysfunction of children and adolescents with type 1 diabetes mellitus: protection by superoxide dismutase? | Q51466626 | ||
| The effects of diabetes and/or polymicrobial sepsis on the status of antioxidant enzymes and pro-inflammatory cytokines on heart, liver, and lung of ovariectomized rats. | Q51591350 | ||
| Comparative study of three angiotensin II type 1 receptor antagonists in preventing liver fibrosis in diabetic rats: stereology, histopathology, and electron microscopy. | Q53149405 | ||
| Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study | Q56997741 | ||
| Implications of the United kingdom prospective diabetes study | Q57232788 | ||
| A simple method for clinical assay of superoxide dismutase | Q68286262 | ||
| Light and electron microscopy of lesions in rats rendered diabetic with streptozotocin | Q72197412 | ||
| Hypoxic and hypercapnic breathlessness in patients with type I diabetes mellitus | Q73681483 | ||
| Relationship of glycation, antioxidant status and oxidative stress to vascular endothelial damage in diabetes | Q74642026 | ||
| Vasoconstriction to endogenous endothelin-1 is impaired in patients with type II diabetes mellitus | Q77478523 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 987-998 | |
| P577 | publication date | 2015-04-07 | |
| P1433 | published in | Journal of Endocrinological Investigation | Q15766847 |
| P1476 | title | The lung endothelin system: a potent therapeutic target with bosentan for the amelioration of lung alterations in a rat model of diabetes mellitus | |
| P478 | volume | 38 |
Search more.